Browse studies

Find your next paid study

1 recruiting study matching your filters

CATALINA-4: Phase 1B/2 Study of TORL-1-23 With Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Newly Diagnosed Patients With Advanced Stage Ovarian Cancer

A Phase 1B/2 Study to Investigate the Safety and Efficacy of TORL-1-23 with Chemotherapy Given Before Initial Surgery in Women with Advanced Stage Ovarian Canc…

FIGO Stage III and IV Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer

TORL Biotherapeutics, LLCNCT07322094